1-3 of 3
Timothy J. Murphy
Close
Save search
Sort by
Journal Articles

Prospective, Multicenter Study Of The Mtor Inhibitor Everolimus (RAD001) As Primary Therapy In Waldenstrom’s Macroglobulinemia

Free
Steven Peter Treon, MD, MA, PhD, Christina K Tripsas, MA, Kirsten Meid, MPH, Christopher Patterson, Leonard T Heffner, MD, Herbert Eradat, MS, MD, Stephanie A. Gregory, MD, Sheeba K. Thomas, M.D., Ranjana H. Advani, MD, Rachid Baz, Ashraf Z. Badros, MD, Jeffrey Matous, MD, Timothy J. Murphy, MD, FACP, Irene M. Ghobrial, MD
Journal: Blood
Blood (2013) 122 (21): 1822.
https://doi.org/10.1182/blood.V122.21.1822.1822
Published: 2013
Journal Articles

Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia

Free
Clinical Trials & Observations
Irene M. Ghobrial, Federico Campigotto, Timothy J. Murphy, Erica N. Boswell, Ranjit Banwait, Feda Azab, Stacey Chuma, Janet Kunsman, Amanda Donovan, Farzana Masood, Diane Warren, Scott Rodig, Kenneth C. Anderson, Paul G. Richardson, Edie Weller, Jeffrey Matous
Journal: Blood
Blood (2013) 121 (8): 1296–1303.
https://doi.org/10.1182/blood-2012-06-439307
Published: 2013
Journal Articles

Final Results of the Phase II Trial of Single Agent Panobinostat (LBH589) in Relapsed or Relapsed/Refractory Waldenstrom Macroglobulinemia

Free
Irene M. Ghobrial, MD, Ranjit Banwait, MA, Tiffany Poon, BS, Federico Campigotto, MS, Erica N Boswell, BS, Stacey Chuma, BSN, Janet Kunsman, NP, Amanda Donovan, BS, Meghan Bagshaw, Diane Warren, Kenneth C. Anderson, MD, Paul G. Richardson, MD, Edie Weller, PhD, Timothy J. Murphy, MD, FACP, Jeffrey Matous, MD
Journal: Blood
Blood (2011) 118 (21): 2706.
https://doi.org/10.1182/blood.V118.21.2706.2706
Published: 2011